P-053 Idecabtagene Vicleucel (Ide-Cel) Retreatment Response Was Characterized by Poor Activation, Impaired Cellular Expansion, and Limited Cytolytic Activity of Chimeric Antigen Receptor (CAR) T Cells
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要